AbbVie Inc banner

AbbVie Inc
BMV:ABBV

Watchlist Manager
AbbVie Inc Logo
AbbVie Inc
BMV:ABBV
Watchlist
Price: 4 564 MXN -0.17% Market Closed
Market Cap: Mex$414.9B

Wall St Price Targets

ABBV Price Forecast
Based on 33 analysts

+5% Upside
from Mex$4 564 today

ABBV Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for ABBV yet.

AbbVie Inc Competitors:
Price Targets

Revenue
Forecast

10% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
10% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 6%.

Gross Profit
Forecast

9% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
9% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 8%.

Operating Income
Forecast

10% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
10% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 11%.

Pre-Tax Income
Forecast

1% / Year
Past Growth
81% / Year
Estimated Growth
Estimates Accuracy
-51%
Average Miss
1% / Year
Past Growth
81% / Year
Estimated Growth
Estimates Accuracy
-51%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 81%.

Net Income
Forecast

-2% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-52%
Average Miss
-2% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-52%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 8 years is 33%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ABBV's stock price target?
Price Target
4 795.81 MXN

According to Wall Street analysts, the average 1-year price target for ABBV is 4 795.81 MXN with a low forecast of 3 318.26 MXN and a high forecast of 5 742.17 MXN.

What is the Revenue forecast for AbbVie Inc?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 6%.

What is the Gross Profit forecast for AbbVie Inc?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 8%.

What is the Operating Income forecast for AbbVie Inc?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 11%.

What is the Pre-Tax Income forecast for AbbVie Inc?
Projected CAGR
81%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 81%.

What is the Net Income forecast for AbbVie Inc?
Projected CAGR
33%

Over the last 13 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 8 years is 33%.

Back to Top